Arrivent BioPharma, Inc. (AVBP)
25.19
+0.22
(+0.88%)
USD |
NASDAQ |
Apr 07, 16:00
25.45
+0.26
(+1.03%)
After-Hours: 04:19
Arrivent BioPharma Shareholders Equity (Quarterly) : 307.22M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ocugen, Inc. | -12.17M |
| Bristol Myers Squibb Co. | 18.47B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Agenus, Inc. | -271.11M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 333.17M |
| Total Liabilities (Quarterly) | 25.94M |
| Current Ratio | 12.83 |
| Net Debt Paydown Yield | 0.00% |